Gene Editing Breakthroughs Boost Stocks
The world of gene editing is buzzing with excitement. Two companies, Crispr Therapeutics and Intellia Therapeutics, are making waves with their latest findings. Their stocks are on the rise, thanks to promising results in treating high cholesterol and a rare swelling disorder. Crispr Therapeutics shared some impressive data at a conference. They found that a single ...